Streetbeat News

RLFTF

Relief Therapeutics Holding SA

https://relieftherapeutics.com/c

Industry

Medicinal and Botanical Manufacturing

Open

6.45

Mkt cap

81M

Volume

800

High

6.50

P/E Ratio

-1.54

52-wk high

7.60

Low

6.45

Div yield

N/A

52-wk low

1.10

Eton Pharmaceuticals has acquired exclusive U.S. rights to PKU GOLIKE from Relief Therapeutics. The transaction is expected to be accretive to Eton's earnings in 2024, with PKU GOLIKE estimated to reach peak sales of over $10 million annually in a U.S. PKU medical formula market worth approximately $100 million annually.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 6:29 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.